Nano-X Imaging (NASDAQ:NNOX) Rating Lowered to Sell at Zacks Investment Research

Nano-X Imaging (NASDAQ:NNOXGet Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Friday, Zacks.com reports.

According to Zacks, “NANO-X IMAGING LTD is a medical imaging technology company. NANO-X IMAGING LTD is based in Neve Ilan, Israel. “

NASDAQ NNOX opened at $9.65 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.80 and a quick ratio of 1.80. Nano-X Imaging has a 1 year low of $8.23 and a 1 year high of $34.50. The company has a market capitalization of $502.57 million, a PE ratio of -6.84 and a beta of 2.68. The company has a fifty day moving average of $10.27 and a two-hundred day moving average of $12.92.

Nano-X Imaging (NASDAQ:NNOXGet Rating) last released its quarterly earnings data on Thursday, May 19th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.19). During the same quarter in the prior year, the business posted ($0.27) EPS. On average, research analysts expect that Nano-X Imaging will post -1.11 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Rockefeller Capital Management L.P. increased its holdings in Nano-X Imaging by 241.3% in the third quarter. Rockefeller Capital Management L.P. now owns 1,273 shares of the company’s stock valued at $28,000 after buying an additional 900 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Nano-X Imaging by 162.5% in the fourth quarter. JPMorgan Chase & Co. now owns 2,965 shares of the company’s stock valued at $43,000 after purchasing an additional 7,711 shares during the last quarter. Quantbot Technologies LP grew its position in shares of Nano-X Imaging by 691.1% in the first quarter. Quantbot Technologies LP now owns 4,462 shares of the company’s stock valued at $48,000 after purchasing an additional 3,898 shares during the last quarter. Macquarie Group Ltd. grew its position in shares of Nano-X Imaging by 27.7% in the third quarter. Macquarie Group Ltd. now owns 3,045 shares of the company’s stock valued at $69,000 after purchasing an additional 660 shares during the last quarter. Finally, State of Tennessee Treasury Department acquired a new stake in shares of Nano-X Imaging in the first quarter valued at approximately $131,000. 13.50% of the stock is owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile (Get Rating)

Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.

Featured Stories

Get a free copy of the Zacks research report on Nano-X Imaging (NNOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.